IBD and Obesity Increases Odds of Treatment Failure in Anti-TNF Therapy
4.8
$ 16.99
In stock
(771)
Product Description
Associations Between Obesity and the Effectiveness of Anti–Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis - Zhang-han Dai, Xi-tao Xu, Zhi-hua Ran, 2020
Overview of TNF Inhibitors for Treating Inflammatory Bowel Disease
How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions, Journal of Nanobiotechnology
Liver Disorders in Inflammatory Bowel Disease - European Medical Journal
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
Influence of first-line anti-TNF therapy on the effectiveness of adalimumab in ulcerative colitis: long-term clinical practice data - ILAPHAR
Diseases, Free Full-Text
The Coronavirus Impact on Diabetes, Obesity, and Immune Diseases: Psoriasis, Irritable Bowel Disease, Multiple Sclerosis
PDF) Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study - The Lancet Gastroenterology & Hepatology
/cloudfront-us-east-1.images.arcpublishing.com/gray/CDJMR2NZRRIWPFY3RWSCYW525M.jpg "Chiefs vs. Lions Predictions & Picks – TNF Week 1")
/cdn.vox-cdn.com/uploads/chorus_asset/file/24223567/TNFWeek12.png "Falcons vs Panthers Week 10 Thursday Night Football picks and predictions - The Falcoholic")
/cdn.vox-cdn.com/uploads/chorus_image/image/69886207/usa_today_16758299.0.jpg)
